MyParkinsonsTeam

Yes, there are new treatment strategies being developed to address brain cell death in Parkinson’s disease:

- Gene Therapy: Researchers are exploring the use of a harmless virus to protect dopamine-producing cells
- Prasinezumab: This drug is being tested in phase 2 clinical trials and is administered intravenously every Show Full Answer

Yes, there are new treatment strategies being developed to address brain cell death in Parkinson’s disease:

- Gene Therapy: Researchers are exploring the use of a harmless virus to protect dopamine-producing cells.
- Prasinezumab: This drug is being tested in phase 2 clinical trials and is administered intravenously every four weeks. The study is scheduled to be completed in 2026.
- UCB0599: An oral drug currently undergoing testing to slow Parkinson’s progression, with the clinical trial scheduled to be completed in 2024.

These efforts aim to slow the progression of Parkinson’s disease by protecting brain cells.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

4 Parkinson’s Advances: How Research Is Improving Treatment | MyParkinsonsTeam

Treatments for Parkinson’s and Parkinsonism | MyParkinsonsTeam